The Herald Sun Sunday Pge94- Share Tips Geoff Saffer
BUY - MSB $9.25 "Biotech's potential recently endorsed with inclusion to ASX 200 index and industry award CEO
What has BTA got. 1. No ASX200 position 2. No industry award CEO 3. MSB $9.25 and firming - with Small cash backing 4. BTA $1.19 just holding with strong cash backing and the market has no confidence or solid knowledge about its product range and potential due to poor profile marketing by the CEO who is most likely past his useby date (been there since 2005
BTA Price at posting:
$1.20 Sentiment: ST Buy Disclosure: Held